Novo hires Fujifilm unit to fill Wegovy injection pens, Reuters reports

Novo Nordisk (NVO) has hired Fujifilm Diosynth Biotechnologies to fill Wegovy injection pens, as the Danish drugmaker scrambles to boost output of its hugely popular weight-loss drug, Reuters’ Maggie Fick reports, citing a person familiar with the matter. Fujifilm Diosynth Biotechnologies, a subsidiary of Japan’s Fujifilm, is the third contract manufacturer Novo has hired to fill Wegovy pens – in addition to Catalent (CTLT) and Thermo Fisher (TMO) – as it spends billions to ramp up production to meet skyrocketing demand and ease shortages, the author notes.